丹参活性成分的现代中药药理研究进展

对传统中药丹参中丹参酮、丹酚酸、丹参单体IH764-3三种主要活性成分及其近年来的中药药理学研究进展进行综述,为进一步开发利用这一传统中药提供理论依据。     

丹参配伍三七和川芎不同提取工艺对丹参酮ⅡA含量的影响

目的：丹参分别配伍三七和川芎经水煎煮和70%乙醇回流后,检测丹参酮ⅡA含量的变化,探究配伍提取后对丹参中可检测成分含量的转移规律。方法：丹参,丹参＋三七,丹参＋川芎,丹参＋三七＋川芎分别水煎煮、70%乙醇回流提取后,用TLC和HPLC方法检测丹参酮ⅡA含量。结果：①全部水煎煮物中基本不含丹参酮ⅡA;②丹参单独醇回流和丹参＋川芎混合醇回流加入三七后,丹参酮ⅡA含量分别上升16.66%和54.97%;③丹参单独醇回流和丹参＋三七混合醇回流加入川芎后,丹参酮ⅡA含量分别下降57.34%和43.33%;④丹参单独醇回流加入三七＋川芎后,丹参酮ⅡА含量下降33.89%;结论：丹参配伍三七显现中药的＂相使＂药性;而川芎对丹参则是＂相恶＂药性,但三七可缓解川芎对丹参的＂相恶＂药性。     

丹参配伍三七和川芎不同提取工艺对丹参酮ⅡA 含量的影响

目的:丹参分别配伍三七和川芎经水煎煮和70%乙醇回流后,检测丹参酮ⅡA含量的变化,探究配伍提取后对丹参中可检测成分含量的转移规律。方法:丹参,丹参+三七,丹参+川芎,丹参+三七+川芎分别水煎煮、70%乙醇回流提取后,用TLC和HPLC方法检测丹参酮ⅡA含量。结果:①全部水煎煮物中基本不含丹参酮ⅡA;②丹参单独醇回流和丹参+川芎混合醇回流加入三七后,丹参酮ⅡA含量分别上升16.66%和54.97%;③丹参单独醇回流和丹参+三七混合醇回流加入川芎后,丹参酮ⅡA含量分别下降57.34%和43.33%;④丹参单独醇回流加入三七+川芎后,丹参酮ⅡА含量下降33.89%;结论:丹参配伍三七显现中药的"相使"药性;而川芎对丹参则是"相恶"药性,但三七可缓解川芎对丹参的"相恶"药性。     

ESI-Q-TOF-MS直接进样法比较陕西五个不同地区丹参的化学成分差异（英文）

该研究采用ESI-Q-TOF-MS直接进样分析法对陕西商州、洛南、大荔、丹凤和铜川等五个地区丹参的化学成分进行了比较分析,通过丹参水溶性和脂溶性成分的质谱丰度差异评价了不同地区丹参化学成分含量的变化,对不同产地丹参的化学成分进行了鉴定,综合分析选出了最优的丹参种植产地。结果表明:五地丹参均含有丹参酮ⅡA、隐丹参酮、丹参酮Ⅰ、二氢丹参酮、丹参酚酮、次丹参醌、丹参醌Ⅱ等9种脂溶性化学成分和丹参素、咖啡酸、阿魏酸、迷迭香酸、原紫草酸、紫草酸、原儿茶醛、丹酚酸A、丹酚酸B等9种水溶性化学成分,其中丹参素钠、紫草酸、丹酚酸B和隐丹参酮的含量普遍较高,质谱丰度均大于30%。但是,随着种植环境不同,不同地区丹参的化学成分含量差异很大,如商州产丹参中含有较多具有生物活性的丹参酮类物质,其中丹参酮Ⅰ含量远远高于其他四个产地,质谱丰度达到72.6%,而其他地区丹参酮Ⅰ的质谱丰度为1.8%～11.3%。这表明丹参质量按照地区排序为商州>铜川>大荔>洛南>丹凤。该方法为中药药材质量评价提供了科学、可靠、便捷的途径,为药材规格等级的制定提供了新途径,为陕西丹参种植区域的选择提供了重要信息。     

ESI-Q-TOF-MS直接进样法比较陕西五个不同地区丹参的化学成分差异

该研究采用ESI-Q-TOF-MS直接进样分析法对陕西商州、洛南、大荔、丹凤和铜川等五个地区丹参的化学成分进行了比较分析,通过丹参水溶性和脂溶性成分的质谱丰度差异评价了不同地区丹参化学成分含量的变化,对不同产地丹参的化学成分进行了鉴定,综合分析选出了最优的丹参种植产地。结果表明:五地丹参均含有丹参酮ⅡA、隐丹参酮、丹参酮Ⅰ、二氢丹参酮、丹参酚酮、次丹参醌、丹参醌Ⅱ等9种脂溶性化学成分和丹参素、咖啡酸、阿魏酸、迷迭香酸、原紫草酸、紫草酸、原儿茶醛、丹酚酸A、丹酚酸B等9种水溶性化学成分,其中丹参素钠、紫草酸、丹酚酸B和隐丹参酮的含量普遍较高,质谱丰度均大于30%。但是,随着种植环境不同,不同地区丹参的化学成分含量差异很大,如商州产丹参中含有较多具有生物活性的丹参酮类物质,其中丹参酮Ⅰ含量远远高于其他四个产地,质谱丰度达到72.6%,而其他地区丹参酮Ⅰ的质谱丰度为1.8%～11.3%。这表明丹参质量按照地区排序为商州>铜川>大荔>洛南>丹凤。该方法为中药药材质量评价提供了科学、可靠、便捷的途径,为药材规格等级的制定提供了新途径,为陕西丹参种植区域的选择提供了重要信息。     

丹参四个栽培类型的脂溶性成分的聚类分析

为给丹参优质新品种选育研究提供一定的理论依据,本文采用HPLC法测定江苏栽培的四个丹参类型的丹参酮IIA、隐丹参酮的含量,采用紫外分光光度法测定其总丹参酮的含量,以DPS软件对其脂溶性成分的HPLC的8个峰的比例、隐丹参酮与丹参酮IIA的比值、丹参酮IIA、隐丹参酮和总丹参酮的含量进行聚类分析。结果表明四个类型丹参的脂溶性成分类别基本一致,其中小叶型丹参的隐丹参酮与丹参酮IIA的比值、隐丹参酮的含量与其它三个类型相差较大,聚类结果显示小叶型丹参独自成为一个类群,说明小叶型丹参为一个较为特殊的类型,也是一个优质的丹参材料。     

丹参酮ⅡA对阿尔兹海默病防治作用的研究进展

阿尔兹海默病(Alzheimer's disease,AD)是一种以老年斑和神经纤维缠结为病理特征的慢性中枢性神经系统退行性疾病,其发病机制非常复杂。丹参酮ⅡA是从中药丹参中分离提取得到的一种脂溶性成分,具有广泛的生物学活性。近年研究发现,其在AD的防治方面发挥着积极的作用,主要体现在抑制Aβ的形成和聚集、抑制tau蛋白异常磷酸化、对神经元的保护等方面。结合最新的研究进展,就AD的发病机制和丹参酮ⅡA对其的防治作用做一综述,为丹参酮ⅡA的进一步开发利用提供参考。     

丹参酮生物合成途径及其相关酶的研究进展

丹参酮是丹参中具有多种药理活性的二萜醌类化合物，对预防和治疗心脑血管系统疾病有显著效果。因其具有重要的经济和药用价值，丹参酮的生物合成研究受到人们的广泛关注。随着丹参基因组和转录组数据的不断积累和完善，以及丹参遗传转化体系的建立和基因编辑技术的应用，丹参酮的生物合成途径解析及相关酶基因研究取得了新进展。现系统阐述丹参酮的生物合成途径与研究进展，同时对合成途径相关酶基因的研究现状进行概述，并展望未来的研究方向。     

脱落酸不同处理时间对丹参毛状根有效成分积累的影响

采用HPLC测定脱落酸(abscisic acid,ABA)处理1、3、6、9 d后丹参毛状根中丹参酮I、隐丹参酮、二氢丹参酮I、丹参酮IIA含量的方法,研究不同ABA处理时间对丹参酮类成分积累的影响。结果表明:①随着ABA处理时间的增加,丹参毛状根生长受到抑制逐渐减弱,并在处理6 d左右变的不显著;②毛状根中四种丹参酮的产量和含量均在ABA处理6 d左右趋于稳定。其中丹参酮I、隐丹参酮、二氢丹参酮I和丹参酮II的产量分别提高为空白对照组的4.65、7.80、18.33和2.11倍;③三种丹参酮类合成抑制剂均对丹参毛状根的生长、丹参酮类的合成有抑制作用。     

丹参酮抗肿瘤研究新进展

丹参酮是一类从传统中药材丹参中提取的醌类化合物,近年研究发现其具有多种生物活性,包括抗氧化,抗炎,抑制增殖,诱导凋亡等作用,本文针对丹参酮自2008年至今的国内外抗肿瘤研究进行综述。     

Role of Salviae Miltiorrhizae Radix extract and its compounds in enhancing nitric oxide expression.

Excessive production of nitric oxide (NO) and its peroxidant product, peroxynitrite, has been implicated in the pathology of acute and chronic renal failure, and inhibitors of NO production have been shown to exert protective and ameliorative effects against renal epithelial cell damage mediated by enhanced generation of NO. Salviae Miltiorrhizae Radix has exhibited a beneficial effect in the improvement of renal failure. In order to clarify the mechanism responsible, we investigated whether Salviae Miltiorrhizae Radix extract and several of its related compounds, including caffeic acid and its polymers which were isolated by our research group, can regulate the generation and release of NO. The results demonstrated that Salviae Miltiorrhizae Radix extract and these compounds suppressed NO effectively in the systems employing activated macrophages and the arginine-hydrogen peroxide, and that, furthermore, the activity shown by the compounds was higher than that shown by the extract. In addition, direct scavenging of NO was also observed. The present findings suggest that Salviae Miltiorrhizae Radix extract and its compounds are potent NO inhibitors, and that their inhibitory effect on the generation and release of NO may contribute to the previously reported pharmacological effect of Salviae Miltiorrhizae Radix in improving renal function.     

中江丹参药材指纹图谱研究

建立四川中江丹参药材的指纹图谱,以期完成中江丹参GAP重要的一环;HPLC法建立丹参脂溶性提取物的指纹图谱;10批中江丹参材指纹图谱符合国家药品监督管理局2000年颁发的关于中药材指纹图谱技术要求;该图谱可作为中江丹参药材质量控制标准之一。     

丹参联合β-榄香烯对肝星形细胞LX-2增殖和凋亡的影响

目的：探讨丹参联合B-榄香烯对肝星形细胞LX-2增殖和凋亡的影响。方法：体外培养肝星形细胞LX-2,分别将丹参（浓度为1、2、4、6、8mg／ml）,β-榄香烯（浓度为25、50、100、150、200μg／ml）,单独作用于LX-2细胞后24h、48h用CCK-8（CellCountKit-8）法检测细胞的增殖情况,并选取合适的药物浓度（丹参3．6mg／ml,β-榄香烯125μg／ml）,然后进行联合用药,加药24h、48h后用CCK-8（Cell CountKit-8）法检测细胞的增殖情况,用流式细胞术检测细胞的凋亡率。结果：OCCK-8法显示丹参（浓度为1、2、4、6、8mg／ml）,8-榄香烯（浓度为25、50、100、150、200μg／ml）作用LX-2细胞24h、48h后,其增殖抑制率均明显高于正常对照组（P〈0．05）,并且呈浓度和时间依赖性。②联合用药（丹参3．6mg／ml,β-榄香烯125μg／ml）时,LX-2细胞的增殖抑制率和凋亡率均显著高于单独用药（P〈0．01）。结论：丹参、β-榄香烯单独或二者联合作用均能抑制LX-2细胞的增殖,且联合应用的作用显著高于单独用药,可协同促进LX-2细胞的凋亡。     

丹参酮ⅡA对正常和氧化损伤内皮细胞的保护作用研究

采用过氧化氢诱导建立的内皮细胞氧化损伤模型,探讨了丹参酮ⅡA对氧化损伤的HUVECs的保护作用.通过内皮细胞LDH、SOD、NOS、GSH-Px的活性和MDA、NO含量的变化趋势,MTT和流式细胞术反映的细胞存活率的变化,研究了丹参酮ⅡA对正常和氧化损伤HUVECs的作用.结果表明丹参酮ⅡA在10～100μmol/L浓度之间时,无明显细胞毒性.浓度在20 μmol/L以上时,丹参酮ⅡA能显著增强HUVECs抵御氧化损伤的能力;同时降低了LDH的泄漏,阻止了MDA等过氧化物的生成,提高了NOS、NO、SOD和GSH-PX分泌量,显著减少了细胞早期凋亡率和坏死率.表明丹参酮ⅡA可以保护HUVECs免受氧化损伤,防止动脉粥样硬化斑块的形成.     

Magnesium Lithospermate B Protects Neurons Against Amyloid β (1–42)-Induced Neurotoxicity Through the NF-κB Pathway

Neurochemical Research - Magnesium lithospermate B (MLB) is one of the major bioactive components of Radix Salviae miltiorrhizae, a Chinese traditional herbal medicine colloquially known as Dan...     

The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression

Tanshinone IIA is one of the major diterpenes in Salvia miltiorrhiza. The inhibitory effect of Tanshinone IIA on atherosclerosis has been reported, but the underlying mechanism is not fully understood. The present study aimed to study the anti-atherosclerosis effect of Tanshinone IIA on the adhesion of monocytes to vascular endothelial cells and related mechanism. Results showed that Tanshinone IIA, at the concentrations without cytotoxic effect, dose-dependently inhibited the adhesion of THP-1 monocytes to the TNF-α-stimulated human vascular endothelial cells. The expressions of cell adhesion molecules including VCAM-1, ICAM-1 and E-selectin were induced by TNF-α in HUVECs at both the mRNA and protein levels. The mRNA and protein expressions of VCAM-1 and ICAM-1, but not E-selectin, were both significantly suppressed by Tanshinone IIA in a dose dependent manner. In addition, the TNF-α-induced mRNA expression of fractalkine/CX3CL1 and the level of soluble fractalkine were both reduced by Tanshinone IIA. We also found that Tanshinone IIA significantly inhibited TNF-α-induced nuclear translocation of NF-κB which was resulted from the inhibitory effect of Tanshinone IIA on the TNF-α-activated phosphorylation of IKKα, IKKβ, IκB and NF-κB. As one of the major components of Salvia miltiorrhiza, Tanshinone IIA alone exerted more potent effect on inhibiting the adhesion of monocytes to vascular endothelial cells when compared with Salvia miltiorrhiza. All together, these results demonstrate a novel underlying mechanism for the anti-inflammatory effect of Tanshinone IIA by modulating TNF-α-induced expression of VCAM-1, ICAM-1 and fractalkine through inhibition of TNF-α-induced activation of IKK/NF-κB signaling pathway in human vascular endothelial cells.     

菊花等十五种中药对大鼠胆固醇代谢的影响

 大鼠口服菊花、郁金及刺五加水煎剂(剂量按药典成人用量折算)三周后,抑制其肝微粒体羟甲基戊二酰辅酶A还原酶的活力,并激活肝微粒体胆固醇7α-羟化酶。在相同状况下,首乌及川芎可抑制羟甲基戊二酰辅酶A还原酶,虽然对胆固醇7α-羟化酶亦有激活作用,但统计学上无意义。泽泻、蒲黄、丹参、黄精、虎杖、延胡索及菌陈等则只抑制肝微粒体羟甲基戊二酰辅酶A还原酶,而对胆固醇7α-羟化酶无作用。黄芪及枸杞对肝微粒体羟甲基戊二酰辅酶A还原酶的活力虽然稍有激活作用,但统计学上无意义。我们实验状况下,上述十五种中药只有菌陈能显著地提高大鼠血清高密度酯蛋白胆固醇的含量。刺五加水煎液对肝微粒体羟甲基戊二酰辅酶A还原酶和胆固醇7α-羟化酶活力调节作用是通过可逆的磷酸化及脱磷酸化作用而实现的。 山楂及刺五加水煎剂,在体外对大鼠肝微粒体羟甲基戊二酰辅酶A还原酶具有强烈的抑制作用。其作用机理亦是通过可逆的磷酸化及脱磷酸化作用进行的。     

Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway

Pathological cardiac hypertrophy induced by adrenergic overactivation can subsequently develop to heart failure which remains as a leading cause of mortality worldwide. Tanshinone IIA is a lipid-soluble pharmacologically active compound extracted from the rhizome of the Chinese herb Salvia miltiorrhiza, a well-known traditional Chinese medicine used for the treatment of cardiovascular disorders. However, little is know about the effect of Tanshinone IIA on cardiac hypertrophy. The present study was aimed to investigate whether Tanshinone IIA prevents cardiac hypertrophy induced by isoproterenol (ISO) and to clarify its possible mechanisms. Cardiomyocytes hypertrophy was induced by ISO 10 μM for 48 h with or without Tanshinone IIA 10, 30, 100 μM pretreatment, and evaluated by determining the cell size and the expression of ANP, BNP, β-MHC, Calcineurin, and NFATc3 by real-time PCR and western blot. We found that Tanshinone IIA pretreatment attenuated the enlargement of cell surface area induced by ISO in cultured cardiomyocytes. The mRNA level of ANP, BNP and β-MHC was obviously elevated in ISO-treated cardiac cells, which was effectively inhibited by Tanshinone IIA. Moreover, we found that Tanshinone IIA pretreatment could prevent the augment of intracellular calcium transient in ISO-treated cardiomyocytes. The further study revealed that Calcineurin, NFATc3, ANP, BNP and β-MHC proteins were upregulated by ISO in ventricular myocytes, and Tanshinone IIA pretreatment significantly attenuate the increased expression of Calcineurin, NFATc3, ANP, BNP and β-MHC proteins. In summary, Tanshinone IIA attenuated cardiomyocyte hypertrophy induced by ISO through inhibiting Calcineurin/NFATc3 pathway, which provides new insights into the pharmacological role and therapeutic mechanism of Tanshinone IIA in heart diseases.     

Danshen-Gegen decoction protects against hypoxia/reoxygenation-induced apoptosis by inhibiting mitochondrial permeability transition via the redox-sensitive ERK/Nrf2 and PKC?/mKATP pathways in H9c2 cardiomyocytes

Danshen-Gegen (DG) Decoction, an herbal formulation containing Radix Salviae miltiorrhizae and Radix Puerariae lobatae, has been used for the treatment of coronary artery disease in Chinese medicine. In the present study, the involvement of ERK- and PKC?-mediated pathways in the cytoprotection against apoptosis afforded by DG pretreatment was investigated in H9c2 cardiomyocytes. Pretreatment with a methanol extract of aqueous DG decoction protected against hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes. The cytoprotection was associated the enhancement of cellular reduced glutathione and a reduced sensitivity to Ca²⁺-induced mitochondrial permeability transition. DG extract increased the production of cytochrome P-450 (CYP)-dependent reactive oxygen species (ROS) in H9c2 cardiomyocytes, which was accompanied by the concomitant activation of ERK1/2 and PKC?. The DG-induced ERK1/2 activation was followed by the translocation of Nrf2 from the cytosol to the mitochondria accompanied by an increase in the expression of glutathione-related antioxidant proteins. In addition, the increased expression of hemeoxygenase-1 was associated with the activation of Akt and BAD, indicative of anti-apoptotic activity. In conclusion, DG treatment activated both ERK/Nrf2 and PKC? pathways, presumably by ROS arising from CYP-catalyzed processes, with resultant inhibition of hypoxia/reoxygenation-induced apoptosis immediately after DG treatment or even after an extended time interval following DG treatment.     

丹参酮ⅡA结构修饰及其对HeLa细胞的抑制作用研究

本研究运用Mannich反应,得到了丹参酮ⅡA的16位被酯化氨基酸取代的5个衍生物,结构均经EI-MS、1H及13C NMR确证。经MTT法测定丹参酮ⅡA及其衍生物对HeLa细胞增殖的抑制作用,并计算出IC50。结果表明,5个衍生物的生物活性较丹参酮ⅡA均有所增强;即丹参酮ⅡA在16位进行结构修饰可以增强其对肿瘤细胞抑制活性。